Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Lansoprazole 3-mg/mL Oral Suspension

Author(s):  Allen Loyd V Jr

Issue:  May/Jun 2010 - Pain Management
View All Articles in Issue

Page(s):  246

Note:  Electronic version includes errata or revisions.

Lansoprazole 3-mg/mL Oral Suspension Page 1

Download in electronic PDF format for $75

Abstract:  A formulation for preparing Lansoprazole 3-mg/mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: formulation, lansoprazole, proton pump inhibitor, peptic ulcer disease, dyspepsia, gastroesophageal reflux disease, GERD, Zollinger-Ellison syndrome

Related Categories: FORMULATIONS, GASTROENTEROLOGY, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease
Corsini Lindsay
, Williams LaVonn A
Mar/Apr 2011
Pg. 124-128

Lansoprazole 3-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2010
Pg. 246

Basics of Compounding for Raynaud's Disease
Glasnapp Andrew
Jul/Aug 2003
Pg. 288-291

Lansoprazole 3-mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
Sep/Oct 2022
Pg. 429

Treating Canine Hepatic Disease
Davidson Gigi S
May/Jun 2003
Pg. 188-191

Lansoprazole 3-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 74

Omeprazole 1 mg/mL and 4 mg/mL in Humco Flavor Sweet Sugar-Free Oral Liquid
Allen Loyd V Jr
Jan/Feb 2019
Pg. 58

Erratum: Formulation: Lansoprazole 3-mg/mL Oral Suspension
May/Jun 2018
Pg. 263

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Lansoprazole 3-mg/mL Oral Suspension
Jan/Feb 2025
Pg. 46

Basics of Compounding for Cough
Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465

Omeprazole 2-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 2006
Pg. 389

Pantoprazole Sodium 2-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 2006
Pg. 391

Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid
Chuong Monica
, Taglieri Catherine A, Huang Szu Yu, Sariol Anthony, Kitigawa Reina, Barman Koushik, Mistry Amee, Harris Donna L, Kerr Stephen G
Nov/Dec 2019
Pg. 504-510

The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment
Meissner Svenja
, Bansal Mahima, Dela Cruz Paula Donamae, Hanning Sara, Svirskis Darren
Mar/Apr 2020
Pg. 140-147

Stability of Omeprazole in SyrSpend SF Alka (Reconstituted)
Whaley Paul A
, Voudrie Mark A II, Sorenson Bridget
Mar/Apr 2012
Pg. 164-166

Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases
Harrington Amy
, Williams LaVonn
Jul/Aug 2022
Pg. 293-296

Incompatibilities of Lansoprazole Injection with Other Drugs During Simulated Y-Site Coadministration
Trissel Lawrence A
, Saenz Christopher, Williams Kimberly Y, Ingram Delshalonda S
Jul/Aug 2001
Pg. 314-319

Stability of Omeprazole Extemporaneous Oral Solution in Chopin Base
Spennacchio Antonio
, Lopedota Angela Assunta, la Forgia Flavia Maria, Fontana Sergio, Denora Nunzio, Lopalco Antonio
May/Jun 2023
Pg. 250-255

Famotidine 8-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 2006
Pg. 382

Return to Top